share_log

HC Wainwright & Co. Maintains Neutral on Co-Diagnostics, Lowers Price Target to $2

Benzinga ·  Aug 14, 2023 05:46

HC Wainwright & Co. analyst Yi Chen maintains Co-Diagnostics (NASDAQ:CODX) with a Neutral and lowers the price target from $3 to $2.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment